Evaluating the role of bromelain in diabetes management: a systematic review of research evidence and mechanisms of action
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf021 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Jaafaru Sani Mohammed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Analysis Department, Tishk International University, Erbil, Iraq. Hauptthemen laut MEDLINE: Bromelains, Diabetes Mellitus, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The use of complementary and alternative medicine is becoming increasingly important in the prevention and management of complications related to diabetes.
Methods
A comprehensive literature search was conducted across major databases (EMBASE, Scopus, PubMed, Google Scholar, Web of Science, Cochrane Library) up to December 2024. The search focused on studies examining the effect of bromelain on glycemic control, lipid profiles, and related mediators in diabetes. Key findings Bromelain supplementation demonstrated positive effects on key metabolic markers. Bromelain may stimulate AMPK in muscle cells, enhancing glucose uptake and utilization, potentially lowering blood glucose levels, and benefiting individuals with diabetes. Although direct evidence of bromelain’s impact on incretin levels is limited, its ability to modulate gastrointestinal function and improve nutrient absorption could indirectly influence incretin secretion. Moreover, Peptides or smaller amino acids resulting from bromelain’s proteolytic activity enter the bloodstream and potentially enhance nutrient absorption, which plays an important role in evaluating the therapeutic potential of bromelain in diabetes management.
Conclusion
Bromelain supplementation is effective in improving glycemic and lipid indices in diabetes. However, further research is needed to clarify the underlying mechanisms, including bromelain’s potential interaction with the incretin system and its role in modulating insulin resistance through various pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Analysis Department, Tishk International University, Erbil, Iraq.
- College of Nursing, University of Al Maarif, Al Anbar, Iraq.
- Directorate of Physical Education and Sports, University of Kashmir, Srinagar, India.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Chandigarh Pharmacy College, Chandigarh Group of Colleges, Jhanjeri, Mohali 140307, Punjab, India.
- Department of Chemistry, NIMS University, Jaipur, India.
ORCID-Profile: Jaafaru Sani Mohammed, Hussein Riyadh Abdul Kareem Al-Hetty
Zitieren
APA
Mohammed, J. S., Ahmed, A. T., Singh, M., Hanumanthayya, M., Kazmi, S. W., Chahar, M., Kareem Al-Hetty, H. R. A., Hulail, H. M., Alasheqi, M. Q., & Zwamel, A. H. (2025). Evaluating the role of bromelain in diabetes management: a systematic review of research evidence and mechanisms of action. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf021
Vancouver
Mohammed JS, Ahmed AT, Singh M, Hanumanthayya M, Kazmi SW, Chahar M, et al. Evaluating the role of bromelain in diabetes management: a systematic review of research evidence and mechanisms of action. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf021
BibTeX
@article{Mohammed2025,
author = {Mohammed, Jaafaru Sani and Ahmed, Abdulrahman T and Singh, Mandeep and Hanumanthayya, Malathi and Kazmi, Syeda Wajida and Chahar, Mamata and Kareem Al-Hetty, Hussein Riyadh Abdul and Hulail, Hanen Mahmod and Alasheqi, Mohammed Qasim and Zwamel, Ahmed Hussein},
title = {Evaluating the role of bromelain in diabetes management: a systematic review of research evidence and mechanisms of action},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf021}
}
EUVIMED